Insider Trading Tue 3/12/24

Notable purchases -- Chief R&D Officer adds to KDP; notable sales -- CBO active in RARE

Buyers:

• CRBP 10% owner Cormorant Asset Management bought 550,000 shares at $37.53 - $46.00 worth ~$23.3 mln.
• CSV Director bought 5,000 shares at $26.10 worth ~$131K.
• FGEN CEO bought 50,000 shares at $1.9094 worth ~$95K.
• HWBK Director bought 5,000 shares at $19.90 - $20.645 worth ~$102K.
• KDP Chief R&D Officer bought 4,075 shares at $29.11 worth ~$119K.
• MOFG CEO bought 4,447 shares at $22.4866 worth ~$100K.

Sellers:

• ATR Segment President and one (1) Director sold 5,500 shares combined worth ~$785K.
• LKFN EVP sold 5,247 shares at $66.75 worth ~$350K.
• MDC Director sold 6,200 shares at $62.69 worth ~$389K.
• RARE Chief Business Officer & EVP sold 11,509 shares at $49.92 - $50.06 worth ~$575K.
• USNA Executive Chairman and COO sold 16,251 shares combined at $48.98 - $49.16 worth ~$797K.

-=USANA Health Sciences (USNA) reported earnings on Tue 5 Feb 2019 (a/h)

SALT LAKE CITY (AP) _ USANA Health Sciences Inc. (USNA) on Tuesday reported fourth-quarter net income of $32.3 million, after reporting a loss in the same period a year earlier.

The Salt Lake City-based company said it had net income of $1.32 per share.

The nutritional supplement maker posted revenue of $299 million in the period.

For the year, the company reported profit of $126.2 million, or $5.12 per share. Revenue was reported as $1.19 billion.

USANA Health expects full-year earnings to be $5.25 to $5.55 per share, with revenue in the range of $1.25 billion to $1.3 billion.

USANA Health shares have fallen slightly since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $117.16, an increase of 65 percent in the last 12 months.

Earnings this week : Feb. 4 - 8, 2019 (wk 6)

Earnings expected this week:

Monday (Feb 4)

• Morning: ALXN CLX ON SYY
• Afternoon: AVB FN GILD GOOG GLUU HIG LM STX

Tuesday (Feb 5)

• Morning: ADM AME ARMK BDX CHD CNC EL EMR ENR INGR IT LII LITE RL 
• Afternoon: ALL APC APU CB CERN DATA DIS DOX  EA MANH  MCHP MODN  MTSI MYGN MXL OI  PAA  PAYC SAVE SCSC  SFLY   SNAP SWKS TCS  TENB ULTI USNA VNOM VRTX ZEN

Wednesday (Feb 6)

• Morning:  ABG BSX BCO CSTE CPRI CTSH CMI ELAN FDC FDV GM HUM LLY  NYT REGN  SPOT TRVG  TTWO 
• Afternoon: ACLS AEL AHL AINV AOSL BLKB CCK CCMP CDAY CENT CINF CMG CSGS CUB CUZ DHT ECHO EGP ELY ENS ENSG FEYE FLO FLT FORM FTNT GBDC GPRO HQY ICHR IRBT KNL LCI LNC MC MET MTCH MTRX NEWR NOV NTGR NTR NXPI ORLY OSUR PAHC PCTY PRU PSDO PSEC RGLD RYN SONO TRMB TTGT TTMI TWO UHAL VVV WERN ZNGA

Wed pm/Thur am (vol) https://finviz.com/screener.ashx?v=211&t=ACLS,AEL,AHL,AINV,AOSL,BLKB,CCK,CCMP,CDAY,CENT,CINF,CMG,CSGS,CUB,CUZ,DHT,ECHO,EGP,ELY,ENS,ENSG,FEYE,FLO,FLT,FORM,FTNT,GBDC,GPRO,HQY,ICHR,IRBT,KNL,LCI,LNC,MC,MET,MTCH,MTRX,NEWR,NOV,NTGR,NTR,NXPI,ORLY,OSUR,PAHC,PCTY,PRU,PSDO,PSEC,RGLD,RYN,SONO,TRMB,TTGT,TTMI,TWO,UHAL,VVV,WERN,ZNGA,ADNT,ADS,AMAG,ANDX,ARW,BCE,BR,BSIG,BV,CAH,CDW,CEIX,CNHI,COR,DNKN,DTE,EIGI,EPC,FCAU,GRA,GRUB,HAIN,HBI,ICE,K,LABL,LCII,LH,MAC,MAS,MD,MMS,MPC,MPLX,MPW,ODFL,PAG,PBH,PENN,PM,PRLB,PTEN,SEE,SNA,SNY,SPB,SPGI,TGI,TKR,TMUS,TPR,TSN,TWTR,VIRT,VSTO,WLTW,WMS,WWE,YUM&ta=0&o=-volume

Thursday (Feb 7)

• Morning: ADNT ADS AMAG ANDX ARW BCE BR BSIG BV CAH CDW CEIX CNHI COR DNKN DTE EIGI EPC FCAU GRA GRUB HAIN HBI ICE K LABL LCII LH MAC MAS MD MMS MPC MPLX MPW ODFL PAG PBH PENN PM PRLB PTEN SEE SNA SNY SPB SPGI TGI TKR TMUS TPR TSN TWTR VIRT VSTO WLTW WMS WWE YUM
• Afternoon: ATEN ATGE ALNY ASYS ANGI MT ATHN BECN BHE BKH CARB CSL CBL CCS COLM OFC DXC EGAN EHC ESE EEFT EXPE FISV FSCT FTV FET FWRD G HUBG IAC KN LGND MTW MCFT MAT MTD MOBL MHK MSI NCR UEPS NR NWSA NUAN OMCL CNXN PMT POWI PRI PRO QRVO QNST RPD RSG SGEN SKX SWI SYNA TDC TBI USX VRSN VVI VSAT VRTU VCRA WTS WU ZAYO 

Friday (Feb 8)

• Morning: ARNC AVA BPL CAE CBOE CLF COTY ESNT EXC GT GRC EAF HAS IMGN PCG PSX  PSXP RDN UNVR VTR 

-=USANA Health Sciences (USNA) reported earnings on Tue 24 July 2018 (a/h)

SALT LAKE CITY (AP) _ USANA Health Sciences Inc. (USNA) on Tuesday reported second-quarter earnings of $33.9 million.

The Salt Lake City-based company said it had profit of $1.36 per share.

The nutritional supplement maker posted revenue of $301.5 million in the period.

USANA Health expects full-year earnings to be $4.75 to $5.05 per share, with revenue in the range of $1.17 billion to $1.2 billion.

USANA Health shares have increased 48 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $109.45, an increase of 72 percent in the last 12 months.

-=USANA Health Sciences (USNA) reported earnings on Tue 24 Oct 2017 (a/h)

USANA beats by $0.11, reports revs in-line; sees FY17 EPS and revs at high end of previous guidance

• Reports Q3 (Sep) earnings of $1.02 per share, $0.11 better than the two analyst estimate of $0.91; revenues rose 3.0% year/year to $261.77 mln vs the $259.52 mln two analyst estimate.
  • There was no meaningful year-over-year impact from changes in currency exchange rates on quarterly net sales.
  • Also, co's total number of active Customers increased by 2.4% year-over-year to 563,000.
• Co issues in-line guidance for FY17, sees EPS of about $3.70 (from $3.50-3.70) vs. $3.79 two analyst estimate; sees FY17 revs approaching $1.03 bln (from $1.015-1.030 billion) vs. $1.03 bln two analyst estimate.

=USANA Health Sciences (USNA) reported earnings on Tue 25 July 2017 (a/h)

SALT LAKE CITY (AP) _ USANA Health Sciences Inc. (USNA) on Tuesday reported second-quarter net income of $23.3 million.

The Salt Lake City-based company said it had profit of 93 cents per share. Earnings, adjusted for non-recurring costs, came to 98 cents per share.

The nutritional supplement maker posted revenue of $257.1 million in the period.

USANA Health expects full-year earnings to be $3.50 to $3.70 per share, with revenue in the range of $1.01 billion to $1.03 billion.

USANA Health shares have increased almost 6 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $64.75, a climb of 2 percent in the last 12 months.